XML 26 R12.htm IDEA: XBRL DOCUMENT v3.6.0.2
Income Taxes
12 Months Ended
Dec. 31, 2016
Income Tax Disclosure [Abstract]  
Income Taxes

Note 5 Income Taxes

The deferred tax assets and deferred tax liabilities and related valuation allowance were comprised of the following:

 

 

  

December 31,

 

 

  

2016

 

 

2015

 

Deferred tax assets:

 

 

 

 

 

 

 

 

Derivative financial instruments

 

$

 

 

$

267

 

Net operating losses

 

 

13,643

 

 

 

5,525

 

Research and development credits

 

 

23,012

 

 

 

21,494

 

Depreciation

 

 

5,457

 

 

 

3,886

 

Valuation reserves and accrued liabilities

 

 

9,667

 

 

 

5,553

 

Foreign tax credit

 

 

6,926

 

 

 

1,654

 

Stock compensation

 

 

4,508

 

 

 

3,129

 

Inventory

 

 

1,571

 

 

 

1,622

 

Patents

 

 

218

 

 

 

156

 

Defined benefit obligation

 

 

2,306

 

 

 

2,011

 

Other credits

 

 

639

 

 

 

639

 

Other

 

 

116

 

 

 

10

 

 

 

 

68,063

 

 

 

45,946

 

Valuation allowance

 

 

(19,304

)

 

 

(13,418

)

Deferred tax liabilities:

 

 

 

 

 

 

 

 

Intangible assets

 

 

(8,442

)

 

 

(10,161

)

Unrealized foreign currency exchange gains

 

 

(285

)

 

 

(3,797

)

Undistributed profits of subsidiary

 

 

(12,002

)

 

 

(3,254

)

Property and equipment

 

 

(470

)

 

 

(696

)

Other

 

 

(319

)

 

 

(342

)

 

 

 

(21,518

)

 

 

(18,250

)

Net deferred tax asset

 

$

27,241

 

 

$

14,278

 

Reconciliations between the statutory Federal income tax rate of 34% and the effective rate of income tax expense for each of the three years in the period ended December 31, 2016 are as follows:

 

 

  

Year Ended December 31,

 

 

  

2016

 

 

2015

 

 

2014

 

Statutory Federal income tax rate

  

 

34.0

%

 

 

34.0

%

 

 

34.0

%

Increase (Decrease) resulting from:

  

 

 

 

 

 

 

 

 

 

 

 

U.S. Taxes on foreign income, net of taxes paid credit

  

 

1.3

%

 

 

1.0

%

 

 

0.3

%

Change in valuation allowance

  

 

5.3

%

 

 

(1.9

%)

 

 

(0.8

%)

Foreign, state and local tax, net of Federal benefit

  

 

1.1

%

 

 

1.6

%

 

 

1.9

%

Nondeductible expenses

  

 

2.4

%

 

 

1.8

%

 

 

1.8

%

Stock option compensation

  

 

 

 

 

(0.1

%)

 

 

(0.1

%)

Research and development credits

  

 

(0.7

%)

 

 

(0.9

%)

 

 

(0.5

%)

Effect of different tax rates of foreign jurisdictions

  

 

(15.0

%)

 

 

(12.1

%)

 

 

(10.0

%)

Undistributed profits of subsidiaries

  

 

7.9

%

 

 

2.4

%

 

 

 

Other tax exempt income

  

 

 

 

 

(0.1

%)

 

 

(0.9

%)

Tax effects of intercompany transfers

  

 

(5.3

%)

 

 

 

 

 

 

Other

  

 

(0.3

%)

 

 

0.3

%

 

 

(0.1

%)

Effective rate

  

 

30.7

%

 

 

26.0

%

 

 

25.6

%

 

Note 5 Income Taxes (Continued)

The Company has Net Operating Loss (“NOL”) carryforwards as follows:

 

Jurisdiction

  

Amount as of
December 31, 2016

 

  

Years of Expiration

 

U.S. Federal and state income tax

  

$

25,364

 

 

 

2018- 2035

  

Foreign

 

$

9,879

 

 

 

2018-2037

 

Foreign

  

$

47,707

 

 

 

Indefinite

  

On April 1, 2014, we acquired all of the stock of GPT in an all cash transaction. The deferred tax assets in 2016 and 2015 related to research and development credits and the offsetting valuation allowance are primarily a result of the GPT acquisition.

A portion of the U.S. Federal NOLs was incurred prior to the June 8, 1999 Preferred Financing, which qualified as a change in ownership under Section 382 of the Internal Revenue Code (“IRC”). Due to this change in ownership, the NOL accumulated prior to the change in control can only be utilized against current earnings up to a maximum annual limitation of approximately $591. As a result of the annual limitation, approximately $6,025 remaining of these carryforwards are expected to expire before ultimately becoming available to reduce future tax liabilities in addition to $13,324 in NOLs generated prior to the change in control which have already expired without being utilized.

In 2014 through 2016, we incurred NOLs in Vietnam associated with the startup activities of new production facilities. In 2015 and 2016, we incurred a loss in Ukraine associated with foreign currency losses. These NOLs are expected to be utilized in 2017 through 2019 as the locations become profitable. We also incur NOLs in Luxembourg associated with our global holding company structure. Management has concluded that it is more likely than not these NOLs will not be utilized, and thus has not recognized the benefit of these NOLs.

We recognize the tax benefit of stock option exercises in excess of compensation expense recorded for financial reporting purposes directly to paid-in capital only when this excess tax benefit provides a reduction to current taxes payable. In certain previous tax years, our U.S. Federal NOLs completely offset our current Federal tax liability and, therefore, we did not recognize the benefit of tax deductions allowed for stock option exercises in excess of compensation expense recognized for financial reporting purposes. As such, in those years, our deferred tax asset related to NOLs was less than the actual NOL available. In 2016, we utilized the entire U.S. Federal NOL carryforward available which included the benefit of tax deductions in excess of compensation expense for financial reporting purposes. We recorded this benefit, which totaled $7,509 and $6,681 for 2016 and 2015, respectively, directly to paid-in capital. The U.S. Federal NOL carryforwards include $0 and $22,343 for 2016 and 2015, respectively, relating to deductions taken with respect to stock option exercises in excess of amounts recognized for financial reporting purposes. The U.S. State NOL carryforwards include $17,564 and $17,213 for 2016 and 2015, respectively, relating to deductions taken with respect to stock option exercises in excess of amounts recognized for financial reporting purposes.  This portion of the NOL carryforwards is not included as a component of the Company’s deferred tax asset.

The earnings before income taxes and our tax provision are comprised of the following:

 

 

  

Year Ended December 31,

 

 

  

2016

 

  

2015

 

  

2014

 

Income before income taxes:

 

 

 

 

 

 

 

 

 

 

 

 

Domestic

 

$

12,981

 

 

$

25,508

 

 

$

11,170

 

Foreign

 

 

97,582

 

 

 

103,430

 

 

 

83,051

 

Total income before income taxes

 

$

110,563

 

 

$

128,938

 

 

$

94,221

 

 Note 5 Income Taxes (Continued)

 

 

  

Year Ended December 31,

 

 

  

2016

 

 

2015

 

 

2014

 

Current income tax expense:

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

9,215

 

 

$

8,428

 

 

$

4,005

 

State and local

 

 

749

 

 

 

606

 

 

 

(15

)

Foreign

 

 

32,844

 

 

 

24,622

 

 

 

24,737

 

Total current income tax expense

 

$

42,808

 

 

$

33,656

 

 

$

28,727

 

Deferred income tax expense (benefit):

 

 

 

 

 

 

 

 

 

 

 

 

Federal

 

$

(10,597

)

 

$

(3,051

)

 

$

(576

)

State and local

 

 

(742

)

 

 

(183

)

 

 

9

 

Foreign

 

 

2,496

 

 

 

3,123

 

 

 

(4,058

)

Total deferred income tax expense

 

$

(8,843

)

 

$

(111

)

 

$

(4,625

)

Total tax expense

 

$

33,965

 

 

$

33,545

 

 

$

24,102

 

The Company has recognized deferred taxes related to earnings from foreign subsidiaries, except for certain foreign subsidiaries for which the earnings are permanently reinvested. Quantification of the deferred tax liability, if any, associated with permanently reinvested basis differences is not practicable.

The Company is subject to taxation in the United States and various state and foreign jurisdictions. As of December 31, 2016, the Company’s tax years from 2008 through 2016 are subject to examination by the various tax authorities. With limited exceptions, as of December 31, 2016, the Company is no longer subject to U.S. Federal, state, local, or foreign examinations by tax authorities for years before 2008. Tax audits are currently ongoing in Germany for tax years 2008 through 2011.

During 2015, to entice the Company to construct a new facility in Macedonia, the government of Macedonia granted the Company a tax holiday that released the Company from the obligation to pay corporate income taxes for a ten year period, subject to certain limitations.  The amount of corporate income tax savings realized by the Company as a result of this tax holiday during 2016 and 2015, respectively, was zero as a result of operating losses generated during each period. The aggregate dollar effect and per share effect of the corporate income tax holiday during 2016 and 2015 was immaterial.

At December 31, 2016, 2015 and 2014, the Company had total unrecognized tax benefits of $4,486, $4,443 and $4,651, respectively, all of which, if recognized, would affect the effective income tax rates. The reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows:

 

 

  

Year Ended December 31, 

 

 

  

2016

 

  

2015

 

2014

 

Balance at beginning of year

 

$

4,443

 

 

$

4,651

 

$

2,241

 

Additions based on tax position related to current year

 

 

80

 

 

 

 

 

43

 

Additions based on tax positions related to prior year

 

 

366

 

 

 

262

 

 

2,991

 

Reductions from settlements and statute of limitation expiration

 

 

(299

)

 

 

(19

)

 

(432

)

Effect of foreign currency translation

 

 

(104

)

 

 

(451

)

 

(192

)

Balance at end of year

 

$

4,486

 

 

$

4,443

 

$

4,651

 

The Company classifies income tax-related penalties and net interest as income tax expense.  In the years ended December 31, 2016, 2015 and 2014 income tax related interest and penalties were insignificant. The Company believes that it is reasonably possible that there may be a decrease to its unrecognized tax benefits in the next 12 months due to audit settlements and statute expirations, but the amount expected to reverse is insignificant in relation to the consolidated financial statements.